US Stock In Play: $AVIR (Atea Pharmaceuticals Inc)$AVIR continue its surge it share price, with a overall cumulative gain of +38.31% since it was last highlighted this month. The continuation of all time high breakout have successfully negated two series of Bearish Shooting Star reversal candlestick pattern that was printed on 14th and 15th January 2021 respectively. This rally have successfully place $AVIR at a market capitalization of $4.5 billion, from the company’s enterprise value at IPO of $1.7 billion on last October 2020.
With daily volume of $AVIR remaining insignificant over the past 4 weeks of market session, price volatility have further up-ticked to $3.60/day range with 6 more weeks to its Q4 earnings.
